93 related articles for article (PubMed ID: 9494589)
41. Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial.
Pentheroudakis G; Kalogeras KT; Wirtz RM; Grimani I; Zografos G; Gogas H; Stropp U; Pectasides D; Skarlos D; Hennig G; Samantas E; Bafaloukos D; Papakostas P; Kalofonos HP; Pavlidis N; Fountzilas G
Breast Cancer Res Treat; 2009 Jul; 116(1):131-43. PubMed ID: 18668363
[TBL] [Abstract][Full Text] [Related]
42. Influence of the time between surgery and radiotherapy on local recurrence in patients with lymph node-positive, early-stage, invasive breast carcinoma undergoing breast-conserving surgery: results of the French Adjuvant Study Group.
Benchalal M; Le Prisé E; de Lafontan B; Berton-Rigaud D; Belkacemi Y; Romestaing P; Peignaux K; Courdi A; Monnier A; Montcuquet P; Goudier MJ; Marchal C; Chollet P; Abadie-Lacourtoisie S; Datchary J; Veyret C; Kerbrat P
Cancer; 2005 Jul; 104(2):240-50. PubMed ID: 15948160
[TBL] [Abstract][Full Text] [Related]
43. [Significance of hormone receptors of breast cancer cells for the duration of a disease-free interval].
Zielinski CC; Kuzmits R; Kubista E; Salzer H; Staffen A; Aiginger P; Spona J
Wien Klin Wochenschr; 1985 May; 97(11):493-7. PubMed ID: 4013343
[TBL] [Abstract][Full Text] [Related]
44. [Prognostic value of estradiol and progesterone receptors in stage I and II breast cancer with an adjuvant treatment].
Bolla M; Bonnabel P; Chedin M; Villemain D; Zins M; Mousseau M; Chambaz E
Bull Cancer; 1987; 74(6):623-30. PubMed ID: 3435786
[TBL] [Abstract][Full Text] [Related]
45. Model for breast cancer survival: relative prognostic roles of axillary nodal status, TNM stage, estrogen receptor concentration, and tumor necrosis.
Shek LL; Godolphin W
Cancer Res; 1988 Oct; 48(19):5565-9. PubMed ID: 3416309
[TBL] [Abstract][Full Text] [Related]
46. [Correlations between estrogen receptor and prognostic factors of patients with breast cancer. The Kanto Cooperative Study Group of Adjuvant Chemoendocrine Therapy for Breast Cancer, Japan].
Tominaga T; Abe O; Izuo M; Isono K; Enomoto K; Nishi M; Fukami A; Muto T; Morioka Y; Watanabe H
Gan To Kagaku Ryoho; 1993 Nov; 20(14):2171-6. PubMed ID: 8239682
[TBL] [Abstract][Full Text] [Related]
47. Blood transfusion and survival after surgery for stage I and II breast cancer.
Herman K; Kołodziejski L
Neoplasma; 1993; 40(2):117-25. PubMed ID: 8350955
[TBL] [Abstract][Full Text] [Related]
48. Stratified multivariate analysis of prognostic markers in breast cancer: a preliminary report.
Younes M; Lane M; Miller CC; Laucirica R
Anticancer Res; 1997; 17(2B):1383-90. PubMed ID: 9137503
[TBL] [Abstract][Full Text] [Related]
49. Prognostic utility of β-tubulin isotype III and correlations with other molecular and clinicopathological variables in patients with early breast cancer: a translational Hellenic Cooperative Oncology Group (HeCOG) study.
Pentheroudakis G; Batistatou A; Kalogeras KT; Kronenwett R; Wirtz RM; Bournakis E; Eleftheraki AG; Pectasides D; Bobos M; Papaspirou I; Kamina S; Gogas H; Koutras AK; Pavlidis N; Fountzilas G
Breast Cancer Res Treat; 2011 May; 127(1):179-93. PubMed ID: 21390496
[TBL] [Abstract][Full Text] [Related]
50. Prognostic significance of p53, angiogenesis, and other conventional features in operable breast cancer: subanalysis in node-positive and node-negative patients.
Gasparini G; Toi M; Verderio P; Ranieri G; Dante S; Bonoldi E; Boracchi P; Fanelli M; Tominaga T
Int J Oncol; 1998 May; 12(5):1117-25. PubMed ID: 9538138
[TBL] [Abstract][Full Text] [Related]
51. [Multi-modal treatment in breast cancer. The prognostic role and correlation between relapse and metastasis].
Munteanu A; Munteanu F; Bild E
Rev Med Chir Soc Med Nat Iasi; 2009; 113(3):941-6. PubMed ID: 20191859
[TBL] [Abstract][Full Text] [Related]
52. [Metastatic cancer of the breast treated by polychemotherapy: a new prognostic approach].
Nadal JM; Jouve M; Mosseri V; Asselain B; Pouillart P
Bull Cancer; 1988; 75(8):757-69. PubMed ID: 3179512
[TBL] [Abstract][Full Text] [Related]
53. [Clinical prognostic factors in breast cancer. Retrospective study of 5609 cases].
Garbay JR; Hacène K; Tubiana-Hulin M; Yacoub S; Rouëssé J
Bull Cancer; 1994 Dec; 81(12):1078-84. PubMed ID: 7742596
[TBL] [Abstract][Full Text] [Related]
54. Prognostic factors of carcinoma of the male breast.
Ouriel K; Lotze MT; Hinshaw JR
Surg Gynecol Obstet; 1984 Oct; 159(4):373-6. PubMed ID: 6484794
[TBL] [Abstract][Full Text] [Related]
55. [Effects of guideline-compliant therapy on the survival of primary breast cancer patients with: results of a retrospective cohort study].
Wolters R; Wöckel A; Wischnewsky M; Kreienberg R
Z Evid Fortbild Qual Gesundhwes; 2011; 105(6):468-75. PubMed ID: 21843852
[TBL] [Abstract][Full Text] [Related]
56. [Prognosis of patients with breast cancer related to the timing of operation during menstrual cycle: a report of 218 patients].
Zhang B; Shao Y; Wang C
Zhonghua Zhong Liu Za Zhi; 1996 May; 18(3):203-7. PubMed ID: 9387255
[TBL] [Abstract][Full Text] [Related]
57. A practical view of prognostic factors for staging, adjuvant treatment planning, and as baseline studies for possible future therapy.
Ravdin PM
Hematol Oncol Clin North Am; 1994 Feb; 8(1):197-211. PubMed ID: 8150780
[TBL] [Abstract][Full Text] [Related]
58. [Evaluation of the effect of ovariectomy in patients with stage III breast cancer].
Semiglazov VF; Moiseenko VM; Filatov VN; Tsyrlina EV; Seleznev IK
Vestn Khir Im I I Grek; 1987 Jan; 138(1):47-50. PubMed ID: 3590535
[TBL] [Abstract][Full Text] [Related]
59. [Prognostic significance of carcinoembryonic antigen and estrogen receptor in patients with breast carcinoma].
Haase W
Strahlenther Onkol; 1995 Mar; 171(3):179-80. PubMed ID: 7709337
[No Abstract] [Full Text] [Related]
60. Observations on short-term and long-term surveys of breast cancer by the American College of Surgeons. I. Significance of the number of axillary nodes and II. Estrogen receptor assay in the U.S. in 1977.
Nemoto T; Vana J; Natarajan N; Bedwani R; Mettlin C
Int Adv Surg Oncol; 1981; 4():209-39. PubMed ID: 7251174
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
